The Dermatologist

FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata

A New Era in Dermatomyositis: A Conversation at the Rheumatology-Dermatology Interface

Myth Buster: Family History is Required to Develop Alopecia Areata

Bibliometric Analysis Highlights Growing Role of Artificial Intelligence in Psoriasis Care

Myth Buster: Steroids are the Only Effective Treatment for Alopecia Areata

Case Report: Atypical Pityriasis Rosea

Myth Buster: Once a Patient Loses all Their Hair, Treatment Won’t Work

Study Identifies 3 Candidate Biomarkers Associated With T-Cell Infiltration in Psoriasis

Clinical Tips: Standardize Before-and-After Photography

Transcriptomic Analysis Identifies Dual Th17/Type 2 Immune Signature in Taiwanese Patients With Psoriasis

How Much Screening Do Modern Therapies Warrant?

Myth Buster: JAK Inhibitors Cure Alopecia Areata

Prediction Models May Improve Early Identification of Psoriatic Arthritis in Patients With Psoriasis

Myth Buster: Alopecia Areata is Caused by Nutritional Deficiencies

Prurigo Nodularis: When Type 2 Inflammation Meets Neuronal Sensitization

Myth Buster: Alopecia Areata Only Affects the Scalp

Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis

AI-Augmented Review Identifies Key Biomarkers in Childhood Atopic Dermatitis

Expanding the HS Treatment Landscape: From Single-Pathway Therapy to Personalized Care

Myth Buster: Wearing Hats or Wigs Makes Alopecia Areata Worse

Fibrosis and Persistent Itch in Prurigo Nodularis

Myth Buster: If Your Hair Grows Back, Alopecia Areata is Gone

Study Finds Treat-to-Target Goals Remain Difficult to Achieve in Atopic Dermatitis

Myth Buster: Alopecia Areata is Just Hair Loss

Closing Gaps in Eczema Research

Myth Buster: Stress Causes Alopecia Areata

Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis

Myth Buster: If Treatment is Working, Patients Can Stop it Immediately

Bibliometric Analysis Highlights Expanding Focus on the Atopic Dermatitis-Inflammatory Bowel Disease Connection

Myth Buster: Patch Size Predicts Disease Severity

Bemotrizinol and UVA Protection: Why This New Sunscreen Filter Matters

Psoriasis May Be Linked to Accelerated Cellular Senescence Through Inflammaging Pathways

What Caused This Recurrent Eruption on the Neck, Ears, and Shoulders?

Machine Learning Identifies Potential Dual-Target Compounds for Atopic Dermatitis

Metformin, GLP-1 Agonists, and Skin Longevity: Emerging Dermatologic Insights

Psoriasis May Be Associated With Greater Treatment Burden in Patients With Inflammatory Bowel Disease

Skin Longevity Skincare: Exosomes, PDRN, and Epigenetic Innovation

Age-Specific Immune Signatures Identified Across the Atopic Dermatitis Lifespan

Insights Into Energy-Based Devices

FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Years

Biologic Therapy Not Linked to Overall Reduction in Psoriatic Arthritis Risk

The Skin Microbiome: Dermatologic Insights

Emergency Department Management of Pediatric Atopic Dermatitis Requires Accurate Triage and Structured Discharge Planning

Neuromodulator Market Trends: New Toxins, Pricing, and Practice Strategy

Perioperative Care: Antibiotics, Anticoagulants, Pain Control, and Anxiolysis

Rosacea and Gut Health: Exploring the Gut-Skin Connection

Spesolimab Shows Potential in Treating GPP With Palmoplantar Pustulosis

Hair Loss Supplements: Evidence-Based Nutraceuticals and Integrative Hair Restoration

Psoriasis Not Genetically Linked to Renal Impairment, Mendelian Randomization Study Finds

Longevity Medicine in Dermatology: Prevention, Diagnostics, and Evidence-Based Innovation

Nail Abnormalities Common in Severe Atopic Dermatitis, Study Finds

Port Wine Capillary Malformations: Laser Treatment and Emerging Options

Neoadjuvant and Adjuvant Immunotherapy in Skin Cancer: Key Updates

Hair Growth Supplements: Evidence-Based Ingredients and Patient Counseling

Managing EGFR Skin Toxicities

Nutrition and Skin Aging: Antioxidants, Inflammation, and Healthy Skin Longevity

A Conversation With Emily Ruiz, MD, MPH

Autoimmune Serologies in Dermatology

GLP-1 Dermatologic Side Effects: Facial Volume Loss, Hair Loss, and Skin Changes

Practical Pearls of Vulvar Dermatoses

BMI, Biological Aging, and Skin Longevity: Beyond Weight in Dermatology

Chronic Hand Eczema: Pathways and Emerging Therapies

Optical Imaging in Dermatology: Real-Time Diagnosis and Noninvasive Skin Cancer Monitoring

Baseline Screening and Monitoring for Biologics and Small Molecules

Sunscreen Trends in Dermatology: SPF, Ingredient Safety, and Skin of Color

To Screen or Not to Screen? Rethinking Biologic Monitoring in the Modern Era

Hidradenitis Suppurativa: Early Recognition, IL-17 Targeted Therapies, and Multidisciplinary Care

Dermatology Retail and Skincare Recommendations: Evidence-Based Strategies for Practices

Improving Dermatology Measures for Skin of Color and Underrepresented Groups

Injectables for the Male Face: Neuromodulator Dosing and Filler Techniques

Mohs Reconstruction Collaboration

Hormonal Therapy in Acne: DHT, Spironolactone, and Clascoterone

June 2026 Issue

Technology Update in Dermatology

Multimodal Biostimulation in Dermatology: PDGF-BB, Hyperdilute CaHA, and Microneedling

Lichen Planus and Lichenoid Dermatoses

Body Contouring in the Age of GLP-1

Cutaneous Lupus Erythematosus: Pipeline Updates, Systemic Risk, and Shared Decision-Making

Devices I Can’t Live Without and What I’m Excited About in 2026

Innovations in Systemic Therapy for Advanced Nonmelanoma Skin Cancers

Update in Immune-Mediated Hair Loss

Buy-and-Bill Model May Improve Access and Practice Control in Dermatology

FDA Approves Bemotrizinol: What Dermatologists Need to Know

Systemic Sclerosis: Emerging Treatments

From Injector to Owner: Aesthetic Business Growth Requires Operational and Financial Readiness

FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis

Cutaneous Immune-Related Adverse Events and Checkpoint Inhibitors

NP-Owned Aesthetic Practices Face Expanding Regulatory and Liability Challenges

Sunscreen Filters: What’s New in UVA Protection, Formulations, and Global Options

Operational Flexibility and Layered Care Strategies Drive Practice Resilience in Dermatology

Advancing Inclusive Outcome Measures in Dermatology

Strategic Planning and Team Alignment Are Central to Successful Practice Sales

Reimagining Hidradenitis Suppurativa Care: Early Recognition, Therapeutic Innovation, and Multidisciplinary Care Across the Patient Journey

Microneedling Radiofrequency Evolves as a Versatile Option for Skin Remodeling

Advances in Dermatomyositis: The Evolving Landscape and Potential Role of Novel Therapies to Improve Disease Outcomes

Obesity and Aging Share Biological Pathways Linked to Longevity Risk

Rapid Neuromodulation and Mast Cell Targeting in Chronic Pruritus

“NoseTox” Techniques Emphasize Muscle Dynamics and Precision Injection

Ultrasound as a Transformative Tool in Dermatology: From Cosmetic Imaging to Hidradenitis Suppurativa Assessment and Emerging Therapies

Fractional Lasers and PDL May Reduce Future Keratinocyte Carcinoma Risk

Pregnancy Dermatoses: The Itchy Patient, the Dangerous Diagnosis, and the Referral That Can’t Wait

Psychiatric Awareness and Boundary Setting Remain Essential in Cosmetic Dermatology

From Psoriasis to Plaque: Why Cardiovascular Risk Belongs in Every Dermatology Visit

Filler Use Shifts Toward Structural Preservation and Long-Term Aesthetic Planning

Allergy 101 for Dermatologists: What to Test, What to Treat, and What to Ignore

Evidence for Longevity-Focused Nutraceuticals Remains Mixed Despite Growing Consumer Demand

Skin Barrier Lipid Dysregulation in Early Infant Eczema: A Window Into Atopy

Oral Icotrokinra Shows Rapid Efficacy Across Skin and Scalp Psoriasis With Favorable Safety

New Visual Scale Aims to Standardize Nail Psoriasis Severity Assessment

Objective Skin Color Measurement May Improve Laser Safety and Treatment Precision

What Caused This Truncal Rash?

Secretomes in Dermatology: Expanding Regenerative Approaches Beyond PRP

Macrophage-Focused Psoriasis Research Shifts Toward Precision Therapeutics

Combination Biostimulation Strategy Aims to Improve Body Contouring Efficiency

Medical Meeting Scams

Stepwise Rejuvenation Strategies Focus on Controlled Injury and Regenerative Support

Lifestyle and Behavioral Interventions Show Adjunctive Potential in Psoriasis Management

HS Immunopathogenesis Drives Expansion of Targeted Therapeutic Strategies

The Latest in Psoriasis Research

IL23R Variant Shows Protective Association in Psoriasis Susceptibility Study

Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis

Next-Generation Fillers Expand Beyond Volume to Regenerative Aesthetics

Andrews’ (& James’) Diseases of the Skin, 14th Edition

Prurigo Nodularis: When Type 2 Inflammation Meets Neural Sensitization

Updated Review Highlights Diagnostic Tools and Treatment Strategies for Scalp Psoriasis

Emerging Therapies Target Mast Cell Pathways in Chronic Spontaneous Urticaria

Congenital Epidermal Loss and Gastrointestinal Obstruction in a Newborn

Disease Biology and Early Recognition in Atopic Dermatitis

Icotrokinra Demonstrates Biologic-Level Efficacy With Oral Administration in Psoriasis

Next-Generation Hyaluronic Acid Fillers for Nasolabial Fold Treatment

Improving New Treatment Adherence

Medical Foods in Dermatology: Expanding the Role of Nutrition in Skin Disease and Aging

Oral VDPHL01 Delivers Rapid, Robust Hair Growth in Phase 2/3 Trial for Male Pattern Hair Loss

Deep Plane Facelift Emphasized as Gold Standard, With Fillers Positioned as Complementary

Chronic Spontaneous Urticaria: Type 2 Inflammation and Mast Cell Hyperreactivity

Cutaneous Pain in Atopic Dermatitis Linked to Higher Psychological Burden

Scar Revision Strategies: When to Intervene and the Role of Laser Therapy

Defining Skin Quality and Optimizing Outcomes With Multimodal Aesthetic Strategies

Exploring GLP-1 Therapy in Psoriatic Disease and Hidradenitis Suppurativa

POEM Scores Align With Clinical Severity and Treatment Intensity in Pediatric Atopic Dermatitis

Circulating CIRP Levels Elevated in Psoriasis, Suggesting Novel Inflammatory Pathway

Nutraceuticals in Hair Loss: Growing Demand Meets Limited Evidence

A Conversation With Crystal Aguh, MD

Managing Immunotherapy and the Future of Advanced BCC Care

Oral Icotrokinra Shows Strong Short-Term Efficacy in Plaque Psoriasis, Meta-Analysis Finds

Redefining Beauty in Dermatology: Cultural Context and Individual Identity Take Center Stage

Artificial Intelligence for Rosacea Diagnosis Shows Both Promise and Shortcomings

Interpolation Flaps in Mohs Surgery: Techniques, Planning, and Common Pitfalls

Oral Icotrokinra Demonstrates High Efficacy and Favorable Safety in Plaque Psoriasis

Evolving AK Treatment Strategies Emphasize Combination Therapy and PDT Optimization

Serial Tacking Sutures to Reduce Seroma Formation in Dermatologic Surgery

QUIZ: Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis

Energy-Based Devices in the Treatment of BCCs

Expanding Hair Growth Strategies Address Metabolic, Hormonal, and Aging Pathways

Laser Focused: The Latest Trends in Laser and Light Devices

Gut-Skin Axis in Rosacea Highlights Emerging Role of Microbiome-Targeted Therapies

Evolution of Aesthetics in Dermatology

Practical Serology Pearls for Dermatologists

PPAR Pathways Link Psoriasis Inflammation With Metabolic Comorbidities, Review Finds

Component-Resolved Diagnostics May Enable Precision Allergen Profiling in Atopic Dermatitis

GLP-1 Agonists in Psoriatic Disease: Beyond Weight Loss to Cardiovascular and Inflammatory Benefit

Quiver Technique to Reduce Persistent Pixel Scarring After Fractional CO2 Laser

Supporting the Transition to Self-Managed Care in Adolescents and Young Adults With Atopic Dermatitis

MicroRNA Networks Identified as Central Regulators in Psoriasis Pathogenesis

Visceral Adiposity Linked to Psoriasis Risk, With Inflammation as Partial Mediator

Review Highlights Gaps Between Clinical Guidelines and Real-World Atopic Dermatitis Care

Biologics, Immunosuppressives, and Pregnancy: What Dermatologists Need to Know in 2026

Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis

Restrictions on Off-Label Prescribing?

Quiz: Disease Heterogeneity in PN

The “Email Yourself” Reflection Habit

A Conversation With Zach Hopkins, MD

Addressing Unmet Needs in Psoriatic Arthritis: Diagnosis, Pathogenesis, and Newer/Emerging Oral Therapies

Altered Lysine Crotonylation Identified in Psoriatic Skin

Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps

Resolution of Nummular Eczema With Mupirocin Monotherapy

From Reactive to Proactive: Building Longitudinal Care Plans That Actually Work for Hidradenitis Suppurativa

What Is This Persistent Scaly Plaque in the Axilla?

Systemic Mastocytosis in Dermatology: Diagnosis and Targeted Therapy

Biosimilars in Dermatology: What Clinicians Need to Know in 2026

Beyond the Gut: Recognizing and Managing Inflammatory Bowel Disease in Dermatologic Practice

Psychometric Study Highlights Gender Differences and Psychological Burden in Psoriasis

Upadacitinib 30 mg Ranks Most Effective Among Targeted Therapies for Atopic Dermatitis Without Topical Corticosteroids

Roflumilast Cream 0.05% Provides Sustained Improvements in Quality of Life and Family Impact in Pediatric Atopic Dermatitis

Vulvar Dermatology Decoded: Contact Dermatitis, Lichen Sclerosus, and the Menopause Overlap

Tildrakizumab Improves Nail Psoriasis Severity and Pain With Sustained Efficacy Through 52 Weeks

Zasocitinib Shows Rapid Onset of Action Linked to TYK2 Pathway Modulation in Plaque Psoriasis

Quiz: Cytokine Hierarchy and Sustained Pruritus in PN

Dupilumab Significantly Increases Itch- and Hive-Free Days in Chronic Spontaneous Urticaria

Upadacitinib 30 mg Emerges as Most Effective Oral JAK Inhibitor for Moderate-to-Severe Atopic Dermatitis in Bayesian Meta-Analysis

Oral Therapies in Psoriasis

Upadacitinib Shows Consistent Efficacy Across Alopecia Areata Subgroups, Including Pediatric and JAK-Refractory Patients

Povorcitinib Demonstrates Meaningful Clinical Response in Anti-TNF–Experienced Hidradenitis Suppurativa Patients at 24 Weeks

Do Not Be Fooled By This Acne Look-Alike

Limited Medicaid Coverage and Prior Authorization Barriers Restrict Access to Topical Ruxolitinib for Vitiligo

Dupilumab Linked to Increased Risk of Vitiligo in Atopic Dermatitis Patients, Though Absolute Risk Remains Low

Why US Sunscreens Lag Behind and Why It Matters for Melasma and Skin of Color

Bimekizumab Demonstrates Sustained 3-Year Efficacy Across Joint, Skin, and Nail Domains in Psoriatic Arthritis

Oral Supplementation Enhances Hair Strength and Collagen VII Expression in Patients With Hair Loss

Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis

Immune Checkpoint Inhibitor–Associated Vitiligo Shows Earlier Onset in Melanoma and Greater Severity With Combination Therapy

Emerging JAK1 and C5a Inhibitors Show Promise in Hidradenitis Suppurativa Network Meta-Analysis

IBD for the Dermatologist: Extraintestinal Clues, Medication Overlap, and When to Refer

Roflumilast Cream 0.3% Improves Skin Clearance and Quality of Life in Plaque Psoriasis Across Adult and Pediatric Patients

Defining and Treating Locally Advanced Basal Cell Carcinoma

Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis

Spesolimab Demonstrates Sustained Reduction in Flare Rates Over 3 Years in Generalized Pustular Psoriasis

Tildrakizumab Improves Burdensome Symptoms and Psychological Well-Being Beyond Skin Clearance in Psoriasis

Advancing Oral Therapies in Psoriasis: Targeted Innovation for Improved Disease Control and Patient Adherence

Delgocitinib Cream Demonstrates Consistent Efficacy in Chronic Hand Eczema Regardless of Prior Systemic Therapy

Tirbanibulin Maintains Durable 1-Year Efficacy With Favorable Safety in Actinic Keratosis Real-World Study

A Conversation With Stephen K. Tyring, MD, PhD, MBA

Rezpegaldesleukin Shows Promising Efficacy Across Disease Severity in Atopic Dermatitis Phase 2b Trial

Upadacitinib Demonstrates Consistent Long-Term Safety Across Age Groups in Atopic Dermatitis Over 6 Years

PBMs, Vertical Integration, and State Reform: Why Dermatology Drug Costs Remain So High in 2026

Higher NB-UVB Phototherapy Intensity Linked to Better Outcomes in Non-Segmental Vitiligo

Risankizumab Significantly Improves Quality of Life in Genital and Scalp Psoriasis at 16 Weeks

ADO Gene Implicated in Skin Barrier Dysfunction and Inflammation in Atopic Dermatitis

Deucravacitinib Improves Fatigue and Quality of Life in Psoriatic Arthritis, Phase 3 Pooled Analysis Shows

Upadacitinib Delivers Rapid, Sustained Improvements in Severe Atopic Dermatitis in Real-World Cohort

Ocular Red Flags in Dermatology: Uveitis, Cicatrizing Conjunctivitis, and Hydroxychloroquine Toxicity

Tildrakizumab Delivers Sustained Skin Clearance and High-Impact Area Control Over 2 Years in Real-World Psoriasis Study

Risankizumab Maintains Radiographic Nonprogression Through 5 Years in Psoriatic Arthritis

Type 2 Inflammation and the Biology of Itch in Prurigo Nodularis

Upadacitinib Drives Robust Hair Regrowth in Adolescents and Adults With Severe Alopecia Areata

Transforming Psoriasis Care: Oral IL-23 Therapy and the Next Frontier in Patient-Centered Treatment

Icotrokinra Delivers Consistent Skin Clearance Across Exposure Levels in Phase 3 Psoriasis Analysis

Do Fungi Play a Role in Rosacea?

Roflumilast Foam 0.3% Improves Signs and Symptoms of Seborrheic Dermatitis in Facial and Scalp Subgroups

Upadacitinib Achieves Consistent Skin Clearance Across Body Regions in Real-World AD-VISE Study

Systemic Sclerosis: From Vasculopathy to CAR-T—Where Are We Now?

Topical Ruxolitinib Shows Favorable Safety Profile Compared With Oral JAK Inhibitor in FAERS Analysis

Psoriasis Linked to Increased Atherosclerotic Risk Regardless of Arthritis Status

Upadacitinib Shows Promising Efficacy in Pediatric Refractory Alopecia Areata With Favorable Safety Profile

Seborrheic Dermatitis Management in 2026

Tirbanibulin Demonstrates Significant Lesion Reduction and Favorable Safety in Actinic Keratosis Over Larger Treatment Fields

QUIZ: Allergic Disease Progression: Genetics and Environment

Risankizumab Significantly Improves Quality of Life in Genital and Scalp Psoriasis at 16 Weeks

Achieving Optimal Skin and Itch Targets Drives Superior Quality-of-Life Outcomes in Atopic Dermatitis

Cutaneous Lupus: Risk of Systemic Progression and a Rapidly Expanding Targeted Therapy Pipeline

Tralokinumab Demonstrates Sustained Real-World Effectiveness in Patients With Skin of Color and Atopic Dermatitis

Systemic Pulse Steroid Therapy Rapidly Stabilizes Vitiligo but Shows Limited Long-Term Disease Control

More Than Cosmetic: Reframing Hyperpigmentation as a Clinical and Psychosocial Priority

Self-Assessment Questionnaires Reveal Mental Health Burden in Psoriasis and Atopic Dermatitis

QUIZ Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making

Vitiligo Associated With Increased Cardiometabolic Risk in Large Retrospective Cohort Analysis

QUIZ Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata

Chronic Hand Eczema: From Pathogenic Subtypes to Targeted JAK and IL-4/13 Therapy

Expectations for JAK Inhibitor Treatment of Alopecia Areata

Urbanization, Lifestyle, and Skin Barrier Damage in Atopic Dermatitis

Managing Immunotherapy and the Future of Advanced BCC Care

Mohs Reconstruction: When to Close, When to Refer, and the Evolving Role of Plastic Surgery

Quiz: Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA

Chronic Itch in 2026: Targeting Th2, IL-31, BTK, and Beyond

Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control

Screening in the Biologic Era: Are Dermatologists Over- or Under-Monitoring in 2026?

Making Our Practice More Productive in 2026

EGFR Inhibitor Rashes: Prophylaxis, Isotretinoin, and When to Culture

Quiz: Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence

Hyperpigmentation Therapeutics: From Hydroquinone Alternatives to Lasers and Oral Tranexamic Acid

Washed Microbiota Transplantation Improves Disease Severity and Microbial Profiles in Moderate-to-Severe Atopic Dermatitis

FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients

Cosmetic Tools in Dermatologic Disease

Metabolic Bariatric Surgery Linked to Psoriasis Improvement, With Response Varying by Procedure Type

Atopic Dermatitis: OX40, IL-31, Treg Therapy, and the JAK Head-to-Head Era

Managing Eyebrow & Eyelash Loss in Alopecia Areata: Emotional Impact & Treatment Insights

Reimagining HS Care in 2026: Earlier Diagnosis, Biologic Durability, and Smarter Surgery

A Novel Technique to Anesthetize the Skin Without Obscuring a Deeply Palpable Lesion

Dermatomyositis: Interferon Biology, Steroid Dependence, and the Rise of JAK/TYK2 Targeting

Quiz: Early Intervention Strategies in Pediatric Atopic Dermatitis

FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis

Cutaneous T-Cell Lymphoma: When to Worry in MF/SS—and What’s Next in Targeted Therapy

What Caused These Changes on the Shins?

Oral Therapy in Psoriatic Arthritis: JAK, TYK2, and the End of Methotrexate Monotherapy?

Managing Cutaneous Squamous Cell Carcinoma

Plaque Psoriasis Treatment Therapeutics: Oral IL-23 Inhibitors

QUIZ: Psychological and Functional Impact of Eyebrow and Eyelash Loss in AA

Vitiligo: JAK Inhibitors, Combination Phototherapy, and Cell-Based Repigmentation

Managing Alopecia Areata With JAK Inhibitors: Timing, Response, and Long-Term Strategy

Checkpoint Inhibitor Rashes: When to Treat, When to Rechallenge, and When It’s Not the Drug

Topical Isosorbide Diesters Improve Itch and Reduce Steroid Use in Pediatric Atopic Dermatitis

Rethinking Seborrheic Dermatitis in 2026: PDE4 Inhibitors, Luliconazole, and Microbiome-Driven Care

Ophthalmology Essentials for Dermatologists: Dry Eye, Cataracts, and Glaucoma in Clinical Practice

Obesity Measures Linked to Psoriasis Risk in Patients With Type 2 Diabetes, Nationwide Study Finds

Artificial Intelligence in Dermatology: From Proof of Concept to Real-World Accountability

AI, Smart Screening, and Smart Glasses: What Dermatologists Need to Know About Tech in 2026

Dermatologic Ultrasound in 2026: Cosmetics and Hidradenitis Suppurativa

Oral IL-23 Therapies in Psoriasis: Addressing Undertreatment, Adherence, and Patient Preference

Precision Under the Surface: Electrical Impedance Spectroscopy for Pigmented Lesion Evaluation

Meta-Analysis Links Atopic Dermatitis to Higher All-Cause and Cause-Specific Mortality

Real-World Registry Data Identify Predictors of Biologic Switching in Psoriasis Care

Position Statement: Routine TB Testing for IL-17 and IL-23 Inhibitors

JAK Inhibitors & Boxed Warnings

Quiz: Why Higher JAK Doses Raise Safety Concerns in AD

Forward Focus: Top Trends in Dermatology for 2026

Network Meta-Analysis Ranks Oral JAK Inhibitors for Short-Term Control of Moderate-to-Severe Atopic Dermatitis

Machine Learning Model Accurately Predicts Hyperglycemia Risk in Patients With Psoriasis

The Dermatologist - January/February 2026

Type 2 Inflammation in Atopic Dermatitis

QUIZ: MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal

A Conversation With Alex Ortega-Loayza, MD

Persistent Facial Redness in a Patient Treated for Rosacea

What Is This Process That Occurs in Hairdressers?

Quiz: Acne Topical Therapy

It Is a Great Time to Be Alive!

5-Fluorouracil Field Therapy for Actinic Keratosis

Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis

QUIZ: What Drives Fibrosis in Chronic Atopic Dermatitis Lesions?

Debunking Sunscreen Myths: Evidence Vs Misinformation

Can Music Effectively Reduce Anxiety in Outpatient Dermatologic Surgery?

Turning Action Plans Into Power: Personalizing Care for Patients With Hidradenitis Suppurativa

“Embracing Inclusive Care:” DNA Annual Convention Preview

Redefining the Standard: Adjuvant and Neoadjuvant Immunotherapy in High-Risk, Advanced CSCC

JAK Inhibitors for Alopecia Areata: Clinical Insights and Emerging Strategies

Rebuilding Confidence in Alopecia Areata: Multidisciplinary, Holistic Support for Patients and Families

JAK Inhibitors in Alopecia Areata: Long-Term Success, Individualized Strategy, and the Emerging Role of Eyebrow Outcomes

Clarifying the Role of IL-13 Inhibitors in Atopic Dermatitis: Clinical Profiles, Comparisons, and Real-World Application

QUIZ: Psychological Sequelae and Identity in AA Regrowth

TYK2 Inhibitors Redefine Systemic Options in Moderate-to-Severe Psoriasis: Mechanism, Selectivity, and Long-Term Response

Rethinking the Role of Orals: Where TYK2 Inhibitors Fit in Psoriasis Management

Oral Therapies in Focus: Where Pills Fit in a Biologic-Dominated Psoriasis Landscape

Integrating GLP-1 Receptor Agonists in Psoriatic Disease: A Dual-Target Approach to Inflammation and Obesity

Insights From Mount Sinai Winter Symposium: Holistic Approaches Treating Alopecia Areata

QUIZ: Insights: Clascoterone Cream 1%

Refining Psoriasis Treatment in High-Impact, Limited Disease: IL-23 Data and Real-World Strategies From Fall Clinical 2025

Charting a Path to Higher Treatment Targets With JAK Inhibition in Atopic Dermatitis

Psoriasis Pearls With Dr Mark Lebwohl: Practical Strategies for Refractory Cases, Combinations, and Cancer Risk

What Is This Lesion on an Older Woman’s Finger?

Part 3: Rebuilding Confidence: Multidisciplinary and Holistic Approaches to Severe Alopecia Areata

QUIZ: The Central Message of World Psoriasis Day 2025

Optimizing Acne Management With Durable Topical and Oral Therapies

QUIZ: Which Systemic Therapy Raises Red Flags in Older Adults?

Simplifying Topical Treatment

Making Those Around Us Feel Welcome, Valued, Heard, and Respected

Challenges and Treatments in Alopecia Areata

Psoriatic Disease and the Domino Effect of Comorbidities

Beyond Weight Loss: GLP-1s Take Aim at Inflammation in Psoriasis and HS

TYK2 Inhibition in Psoriasis: New Pathways, New Possibilities

QUIZ: When Should You Start a JAK Inhibitor for AA?

Hidradenitis Suppurativa: Phenotypes, Pitfalls, and Expanding Treatments

Reframing Generalized Pustular Psoriasis: From Pathogenesis to Early Clinical Intervention

Beyond the Rash: Targeted Strategies for Skin Toxicities in Oncology

A Surgeon’s Map: The Power and Precision of Mohs Surgery

Psoriasis Treatment in 2025: New Approvals, Expanded Indications, and a Push Toward Remission

Latest Acne and Rosacea Therapies Unveiled at Dermatology Week

Microbiome Matters: Connecting the Gut, Skin, and Joints in Inflammatory Dermatoses

Managing EGFR Inhibitor Dermatologic Toxicities

What You’re Missing in Rosacea: A Deeper Dive Into Diagnosis and Treatment

Quiz: Risk of Developing Psoriatic Arthritis in Patients with Psoriasis

Raising the Bar on Sun Protection: Inside the Skin Cancer Foundation’s Seal of Recommendation

Quiz: Pathophysiologic Pillars of Acne

A Conversation With Avrom S. Caplan, MD

Untangling the Risks: Rethinking Hair Product Regulation in the United States

QUIZ: How Long Before You Call a JAK Inhibitor Non-Responsive?

New Study Finds Skin Microbiome Differences Between Rosacea and Similar Conditions

Advances in Topical Acne Treatments: Balancing Efficacy with Patient Safety

Psychosocial Impact of Alopecia Areata in Pediatric Populations

Monitoring Patients on Systemic Treatments: Deucravacitinib

Chronic Hand Eczema: Breaking Out of the Atopic Dermatitis Umbrella

Redefining Remission and Low Disease Activity in Dermatology

NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network

Points Programs for Products and Services

Grow With the DNA

A Conversation With Abby S. Van Voorhees, MD

The Dermatologist - October 2025

FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5

Talking Through the Risks and Benefits With Our Patients

QUIZ: What’s the Go-To Adjunct With JAKs in AA Regrowth?

Optimizing HS Visits: A Dermatologist’s Guide to Compassionate, Effective Care

Eczema Action Plans: Personalized Tools for Empowering Patients and Enhancing Care

Two Roads Diverging: The Future of Patient Communication in the Era of Artificial Intelligence

Salon to Skin: How Dermatologists and Hair Stylists Can Work Together

Bridging Specialties for Better Care: The Cardiovascular-Dermatology Interface

QUIZ: Alopecia Areata—JAK Inhibitor Indications

Rosacea in Older People: Less Common or Underdiagnosed?

An Integrated System

GLP-1 Agonists: Implications for Dermatology

Part 2: Advancing the Treatment Landscape in Severe Alopecia Areata

A Conversation With Elena Netchiporouk, MD

What’s the Gold Standard in Managing Chronic TH2 Dermatoses?

Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity

Advances in Alopecia Areata Treatment and Assessment

Part 2: From Topicals to Biologics: Evolution of Treatment Options in Severe Alopecia Areata

FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11

Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap

Ethical Arguments in AA: Cosmetic vs. Medical

Managing the Side Effects and Adherence of JAK Inhibitors for Patients With Severe Alopecia Areata

Systemic Treatments for Special Populations in Dermatology

Janus Kinase Inhibitors and Alopecia Areata: From Data to Dialogue

Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds

QUIZ: Medical Minimization of AA: What Contributed Historically?

Topical Therapies for Pediatric AD

Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis

New Issue - September 2025

Prevalence and Management of Alopecia Areata in Black and Asian Patients

How to Approach Integrative Medicine

Alopecia Areata—JAK Inhibitors

The Role of IO Therapy in ​Advanced Non-Melanoma Skin Cancer

Getting Patients to Wear Compression Stockings

Rapid Refresh: Head and Neck Eczema

Improving Lives With Alopecia Areata Treatment

What Is This Yellowish, Erythematous Papule?

True or False: TYK2 Inhibition

Integrated PsA Screening Framework Improves Outcomes in Dermatology Clinics

Derm Advances: Insights From Dr Hamid on the Phase 3 C-POST Trial Results

Eczema in the United States: Insights from a National Study on Prevalence and Co-Occurrence

TYK2 as a Therapeutic Target in Psoriasis

Understanding the Emotional and Physical Toll of Alopecia Areata

QUIZ TH2 vs TH1: Can You Differentiate PN from Psoriasis?

Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis

Resources for Patients With Alopecia Areata

Libtayo Shows Promise as Adjuvant Therapy in High-Risk CSCC: Phase 3 C-POST Trial Results

Study Finds Higher Fertility Rates Among Men With Inflammatory Joint Disease

QUIZ: What Sets JAK Inhibitors Apart in TH2 Dermatoses?

Part 1: The Emotional and Physical Toll of Severe Alopecia Areata

Infusion Therapy for Non-Melanoma Skin Cancer: A Dermatologist’s Guide

Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis

Insights From Mount Sinai Winter Symposium: Holistic Approaches Treating Alopecia Areata

What Caused This Alopecic Lesion on the Scalp?

Quiz: Why Is Alopecia So Emotionally Impactful? Evolution Holds Clues

Expert Perspectives: Hair Loss Management in Dermatology Practice

Multiple Sclerosis and Psoriasis

Type 2 Inflammation in Atopic Dermatitis

Part 1: The Emotional and Physical Toll of Severe Alopecia Areata

Bridging Specialties for Better Care: The Cardiovascular-Dermatology Interface

QUIZ: Why Do Biologics Like Dupilumab Work in AD?

The Reality of Alopecia Areata: Dispelling Myths and Raising Awareness, Part 1

Key Immune Markers of TH2 Skin Disease: Can You Spot Them?

Advances in Alopecia Areata Treatment and Assessment

QUIZ: IL-4 and IL-13 in AD: What's Their Pathogenic Power?

What’s New in Allergic Contact Dermatitis? 2025’s Allergens on the Rise

Gram-Negative Cellulitis Presenting as Unilateral Lower Extremity Purpura

Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management

QUIZ: The Overlooked Allergen Missing from Most Patch Test Panels

Rapid Refresh: Types of Vitiligo

QUIZ: Which Immune Cell Doesn’t Drive Type 2 Inflammation?

TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds

Managing the Side Effects and Adherence of JAK Inhibitors for Patients With Severe Alopecia Areata

QUIZ: Tacrolimus Aggravating Symptoms? Know the Next Best Step

Precision Over Complexity: Honoring Mohs Principles in Modern Reconstruction

JAK Inhibitors for Alopecia Areata

QUIZ: Making Sense of HECSI Scores in Trials

Role of Th2 Immune System in Dermatology

The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective

QUIZ - The Hypoallergenic Paradox: Which Common Additive Can Trigger ACD?

The Impact of Eyebrow and Eyelash Loss

Early Use of Biologics in Psoriasis May Alter Inflammatory Course, Improve Comorbidities

QUIZ: Distinguishing Feature of Generalized Pustular Psoriasis

The Elderderm: Episode 5, Deep and Dutiful Dialogues about Down Below

IL-23/IL-17 Axis Central to Psoriatic Arthritis Pathogenesis, Study Finds

QUIZ - Validating HEIS: Internal Consistency to Clinical Relevance

Atypical Desmoplastic Melanoma in an African American Man

Mohs Surgery for Anogenital and Perineal Tumors: Expert Insights

QUIZ - Hair Product Allergen Exposed: What’s Causing This Dermatitis Pattern?

Skin Disease and the History of Dermatology: Order Out of Chaos

Assessing and Managing Infectious Disease in Children

Why AD Patients Stop Using Their Medication

A Conversation With Erin Barrett, MD

Breakthroughs in Pediatric Atopic Dermatitis Care

Quiz: Misdiagnosis of Generalized Pustular Psoriasis

Clinical Classifications and Treatment Aproaches for Actinic Keratosis

What’s Still Needed in Delgocitinib Research

Dupilumab Shows Promise in Reducing COPD Exacerbations and Improving Lung Function

Navigating the Corporate Structure to Get What You Need: Part 4

June is Hidradenitis Suppurativa Awareness Week

Type 2 Inflammation and Treatment Targets in Atopic Dermatitis

Quiz: Biomarkers in Chronic Hand Eczema

Psoriasis and Type 2 Diabetes: Review Highlights Bidirectional Inflammatory Link and Need for Integrated Management

IL-23 and IL-17 Inhibitors Linked to Lower Risk of Psoriatic Arthritis in Patients with Plaque Psoriasis

QUIZ: How Delgocitinib Works in Chronic Hand Eczema

FDA Approves Dupilumab as First Targeted Treatment for Bullous Pemphigoid in Adults

How I Treat: Generalized Pustular Psoriasis Case Presentation

Basics of Rosacea

What Is This Painless Solid Mass on the Upper Eyelid?

Melanoma in Special Patient Populations

Milia en Pickle: A Case of Pickleball-Induced Milia en Plaque

Delgocitinib: Symptom Relief and Safety Profile

Why Preoperative Consultations Matter: A Case for Better Planning in Dermatologic Surgery

Environmental Factors Play a Major Role in Atopic Dermatitis

Missouri’s Call, ECHO’s Answer: Expanding Access to Psoriasis Care

Emerging Imaging Technologies Offer New Precision in Psoriatic Arthritis Diagnosis and Management

Biologic Therapy May Lower Risk of Psoriatic Arthritis in Patients With Psoriasis, Study Finds

Dupilumab Shows Long-Term Efficacy in Children with Type 2 Asthma, Regardless of Allergy Status

Optimizing Hidradenitis Suppurativa Care

June 2025 Issue

The Latest in Rosacea News

The Screening Dilemma: Rethinking Melanoma Detection

Targeting Itch in Atopic Dermatitis: Cytokines and Novel Therapies

Breaking Down the ‘4 Horsemen of Itch’

Common Etiological Subtype of Chronic Hand Eczema

Tai Chi and Pickleball

Clinical Subtype of Chronic Hand Eczema

Proteomic Advances Highlight Promising Biomarkers for Psoriatic Arthritis Diagnosis

Adherence to Atopic Dermatitis Treatment

International Panel Defines Generalized Pustular Psoriasis for Clinical and Research Use

Exploring the Link Between Stress and Skin Disease

Bridging the Gap Between Psoriasis and Cardiovascular Disease Risk

Expert Panel Recommends Updated TB Screening Approach for Patients With Psoriasis on Targeted Therapies

Navigating Neuromodulators in 2025

FDA Approves Roflumilast Topical Foam 0.3% for Scalp and Body Plaque Psoriasis in Adults and Adolescents

Test Your Knowledge: Key Cytokines in Atopic Dermatitis

Latest Acne and Rosacea Therapies Unveiled at Dermatology Week

Navigating the Corporate Structure to Get What You Need: Part 3

Quiz: Delgocitinib in Chronic Hand Eczema

Expanding the Role of Oral Tranexamic Acid in Dermatology: Anti-Pigment, Anti-Inflammatory, and Barrier Repair

Laser and Energy-Based Device Safety in Skin of Color: A Stepwise Framework

Malignancy and Psoriasis Treatment

Isotretinoin’s Ocular Effects

Surgical Reconstruction Planning for Optimal Outcomes

A Conversation With Scott Stratman, MD

Surgical Insights From ACMS

Manage Acute Flares in Atopic Dermatitis

Comorbidities Associated With Vitiligo

Chronic Hand Eczema: DELTA FORCE Trial Quiz

Emerging Psoriasis and Psoriatic Arthritis Therapies Expand Treatment Landscape

Breakthroughs in Skin Cancer Care: Emerging Treatments

Exploring the Inflammatory Link Between Psoriasis and Psychiatric Comorbidities

JAK Inhibitors in Atopic Dermatitis Treatment

Pediatric Common Infections

Advancing Itch Management With Emerging Therapies and Neuromodulation

Print Issue: April/May 2025

The Reality of Alopecia Areata: Dispelling Myths and Raising Awareness, Part 1

What Caused These Papules on the Ears?

Topical Treatment Challenges in Type 2 Inflammatory Skin Conditions

The Role of Patient-Centered Communication in Alopecia Areata Treatment, Part 1

Addressing Acute Care Needs in Atopic Dermatitis: A Call for Improved Access and Management

Study Identifies Unidirectional Link Between Primary Biliary Cirrhosis and Psoriasis Risk

Updated Evidence Reinforces Efficacy and Safety of Pharmacologic Therapies in Psoriatic Arthritis

FDA Approves Dupilumab (Dupixent) for Chronic Spontaneous Urticaria in Patients Aged 12 and Older

Systemic Treatments for Type 2 Inflammation

Biologic Class May Influence Psoriatic Arthritis Risk in Patients With Plaque Psoriasis

Identifying The Appropriate Patient for IO Therapy in Advanced Non-Melanoma Skin Cancer

The Role of IO Therapy in ​Advanced Non-Melanoma Skin Cancer

Operational and Logistical Considerations With IO Therapy for Advanced Non-Melanoma Skin Cancer

Real-World Case Studies and Insights on IO Therapy for Advanced Non-Melanoma Skin Cancer

Dupilumab Effective in Young Children with Eczema, Regardless of Type 2 Inflammatory Comorbidities

Alopecia Areata in Children

Publish or Perish?

AAD 2025 Recap: Advanced Skin Cancer

Elevate Care in Advanced Non-Melanoma Skin Cancer: Free Virtual Summit on May 1—Explore IO Strategies & Treatment Evolution

Alopecia Areata Expert Insights: Addressing Key Challenges and Advancing Patient Care

Clinical Pearls: Proactive Therapy for AD

Comorbidities in Psoriasis Video Series

New Meta-Review Highlights Prevalence and Psychological Burden of Psoriatic Arthritis

International Consensus Defines Generalized Pustular Psoriasis for Clinical and Research Use

Navigating Advanced Basal Cell Carcinoma and Advanced Cutaneous Squamous Cell Carcinoma Care

QUIZ: Distinguishing Feature of Generalized Pustular Psoriasis

Topical Treatments for Type 2 Inflammation

Advancements in the Locoregional Treatment of Merkel Cell Carcinoma

QUIZ: Patient-Provider Alignment on AD Flare

Expanding the Scope of Psoriatic Disease: Beyond the Skin

Risk of Psoriatic Arthritis Development in Patients with Subclinical PsA

Skin Cancer Within Special Populations

Barrier Repair & Inflammation Control in Atopic Dermatitis

Underdiagnosis of Skin Cancer in Veterans Identified in Quality Improvement Study

Innovations in Non-Surgical Hair Restoration

Key Parts of The Flare Experience

Treating Generalized Pustular Psoriasis

Non-Surgical Treatment For Skin Cancer

Pathogenesis Mechanism of Actinic Keratosis

A Conversation With Walter Liszewski, MD

Indicators of an AD Flare

Poor Adherence and Persistence With Biologics for Generalized Pustular Psoriasis

Evidence Based Management of Rare Tumors

Study Fails to Validate Perineural Invasion Score as a Predictor of Adverse Events in cSCC

Environmental Triggers of Barrier Damage & Type 2 Inflammation

Roflumilast Cream for Atopic Dermatitis in Pediatric Dermatology

Impact of Laser Refraction and Ambient Light on Sensor-Based Automatic Hand Sanitizer Dispensers

Metabolic Syndrome in Psoriatic Arthritis Linked to Degenerative Spinal and Enthesopathic Changes

Quiz: Misdiagnosis of Generalized Pustular Psoriasis

AAD 2025: Approaching Skin Cancer Diagnosis

Congestive Heart Failure and Psoriasis

Navigating the Corporate Structure to Get What You Need: Part 2

Post Ambulatory Swollen Hands

Beyond Face Value: Targeted Therapies for Vitiligo and Strategies for Improving Patient Quality of Life

March 2025 Issue

Biologic Therapy in Psoriasis: No Significant Increase in Cancer Risk

Distinguishing Erythema Multiforme from EM-Like Reactions

Advances in High-Risk Cutaneous Squamous Cell Carcinoma

Environmental Impact on Atopy

Hyperglycemia and Alcohol Consumption Linked to Psoriasis Flares in Severe Cases

Biologic Class May Influence Psoriatic Arthritis Risk in Patients With Plaque Psoriasis

Living With Advanced Basal Cell Carcinoma: A Patient's Treatment Journey

Psoriasis-to-Psoriatic Arthritis Transition Time Linked to Disease Activity but Not Radiographic Progression

Type 2 Inflammation and Fibrotic Pathways Drive Localized Scleroderma

Eosinophilic Granulomatosis With Polyangiitis

Test Your Knowledge: Diagnosing Alopecia Areata

Insights into Women's Health in Dermatology

Why Alternative Medicine?

The Alopecia Areata Severity Scale

A Complete Unknown

Nemolizumab Receives EU Approval for Atopic Dermatitis and Prurigo Nodularis

What Is This Pink Papule on the Right Knee?

Dupilumab Therapy Reduces Systemic Inflammation in Prurigo Nodularis

Navigating the Corporate Structure to Get What You Need: Part 1

Erythema Multiforme-Like Reaction Secondary to Poison Ivy Contact Dermatitis

Managing Pediatric Alopecia Areata: Part 2

Hormonal Intrauterine Devices May Increase Rosacea Risk

Highlights From the 2024 Psoriasis Health Indicator Report

What Constitutes a Flare? The Patient Perspective

Quiz: Understanding Type 2 Inflammation: Pathways and Treatment Options

A Conversation With John Harris, MD, PhD

The Psoriasis–CVD Link: How Dermatologists Can Support Patients With Psoriasis and Comorbid Cardiovascular Disease

Clinical Considerations in Patients With Psoriasis: Hepatic Disease

Key Insights on Psoriasis in Patients With Skin of Color

How to Ask About Itch

Addressing Inflammatory Skin Conditions in Diverse Populations

Cryptocurrency in Dermatology

Traceability in Artificial Intelligence: A Critical Look at Platforms in Dermatology

January/February Issue 2025

FOSL1 Identified as a Potential Biomarker for Psoriasis Activity and Response to Therapy

Senescent CD8+ T Cells Linked to Pathogenesis in Spondyloarthritis and Psoriatic Arthritis

Inflammatory Skin Conditions in Skin of Color

Immune Triggers Linked to Chronic Pruritus and Elevated Type 2 Inflammation

Keys to a Successful Dermatology Practice

Evolution of the Dermatology Care Team

Clinical Manifestations of Rosacea

Clinical Presentation of Hidradenitis Suppurativa

Causes and Epidemiology of Keloids

Skin Complications of Gastrointestinal Diseases

Basics of Venous Disease

Clinical Features and Epidemiology of Prurigo Nodularis

Challenges in Diagnosing Cutaneous T-cell Lymphoma

Differential Diagnosis of Hidradenitis Suppurativa

Dupilumab Linked to Lower Risk of Upper Respiratory Infections in Patients With Atopic Dermatitis

Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata

Retaining and Recruiting Exceptional Staff

Phase 3 Trial Demonstrates Significant Benefits of Libtayo in High-Risk Cutaneous Squamous Cell Carcinoma

Type 2 Inflammation in Atopic Dermatitis

Welcome to the APP Institute Dermatology

Basic Mechanisms of Itch

AI in Dermatology

Basics of Vitiligo

Systemic Therapies for AD

Defining Difficult-to-Treat Psoriatic Arthritis: A Scoping Review

Study Links Psoriasis to Increased Dementia Risk

Tobacco Smoke Exposure Unlikely to Worsen Atopic Dermatitis in Youth

Childhood Psoriasis: Emotional Toll on Families During Adolescence

Pongamia Pinnata Extract as a Potential Treatment for Skin Cancer

Sarcopenia and Osteoporosis: Overlapping Risks in Patients With Psoriatic Arthritis

Mulberry Extract Shows Promise in Treating Atopic Dermatitis

Acne Vulgaris Associated With Gastrointestinal Issues

The Complexities of Diagnosis and Assessment of Alopecia Areata

The Complexities of Diagnosis and Assessment of Alopecia Areata

Managing Psoriasis in Patients With Obesity: A Multidisciplinary Approach

What You Should Know About Ritlecitinib

Therapeutic Relevance of Sebum in the Pathophysiology of Acne Vulgaris

Targeted Precision Cryotherapy Treatment for Acne Lesions

Apremilast for Pediatric Patients With Moderate To Severe Plaque Psoriasis

Topical Clindamycin: A Safe Choice for Acne Treatment Despite GI Concerns

Primary Biliary Cirrhosis and Psoriasis Co-Occurrence

Atopic Dermatitis and JAK Inhibitors

Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice

PSA for PsA: A Mnemonic for Evaluating Psoriatic Arthritis Risk